The current role of radiofrequency ablation in the management of hepatocellular carcinoma: A systematic review

Annals of Surgery

Volumn 249, Issue 1, 2009, Pages 20-25

  Lau, Wan Yee ^a,b   Lai, Eric C H ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALCOHOL; ALPHA FETOPROTEIN;

CANCER SURVIVAL; CHOLECYSTITIS; CLINICAL TRIAL; COHORT ANALYSIS; DRUG MEGADOSE; EVIDENCE BASED PRACTICE; FEASIBILITY STUDY; FOLLOW UP; HEMATOTHORAX; HEMOBILIA; HEMOPERITONEUM; HUMAN; INJECTION; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; MICROWAVE THERAPY; NEEDLE BIOPSY; PARTIAL HEPATECTOMY; PLEURA EFFUSION; PORTAL HYPERTENSION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; RECURRENT CANCER; REFERENCE DATABASE; REVIEW; STOMACH PERFORATION; SYSTEMATIC REVIEW; THERAPY EFFECT; TUMOR GROWTH; TUMOR VOLUME; ULTRASOUND; CATHETER ABLATION; LIVER TUMOR;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; HUMANS; LIVER NEOPLASMS;

EID: 58749083265     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31818eec29     Document Type: Review

References (63)

1. Lau WY. Primary Hepatocellular Carcinoma. In: Blumgart LH, Fong Y, eds. Surgery of the Liver and Biliary Tract. 2nd ed. Vol II. London, England:W.B. Saunders; 1423-1450:2000.
2. Lai EC, Lau WY, Mann DV. Selection of Patients for Liver Resection. In: Lau WY, ed. Hepatocellular Carcinoma. Singapore, Republic of Singapore: World Scienti?c Publishing Co. Pte Ltd; 303-316:2008.
3. Belghiti J. Surgical Treatment. In: Lau WY, ed. Hepatocellular Carcinoma. Singapore, Republic of Singapore: World Scienti?c Publishing Co. Pte. Ltd; 387-408:2008.
4. Lau WY. Management of hepatocellular carcinoma. J R Coll Surg Edinb. 2002;47:389-399.
5. Lau WY, Lai EC. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int. 2008;7:237-257.
6. Lai EC, Lau WY. The continuing challenge of hepatic cancer in Asia. Surgeon. 2005;3:210-215.
7. Lau WY, Yu SC, Lai EC, et al. Transarterial chemoembolization for hepa- tocellular carcinoma. J Am Coll Surg. 2006;202:155-168.
8. Lau WY, Leung TW, Yu SC, et al. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg. 2003;237:171-179.
9. Livraghi T. Local Ablative Therapy. In: Lau WY, ed. Hepatocellular Carcinoma. Singapore, Republic of Singapore: World Scienti?c Publishing Co. Pte. Ltd; 2008:645-660.
10. Galandi D, Antes G. Radiofrequency thermal ablation versus other interven- tions for hepatocellular carcinoma. Cochrane Database Syst Rev. 2004;2: CD003046.
11. Sutherland LM, Williams JA, Padbury RT, et al. Radiofrequency ablation of liver tumors: a systematic review. Arch Surg. 2006;141:181-190.
12. Shibata T, Iimuro Y, Yamamoto Y, et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coag- ulation therapy. Radiology. 2002;223:331-337.
13. Lu MD, Xu HX, Xie XY, et al. Percutaneous microwave and radiofre- quency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol. 2005;40:1054-1060.
14. Ohmoto K, Yoshioka N, Tomiyama Y, et al. Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carci- nomas: a retrospective comparative study. Hepatogastroenterology. 2007;54: 985-989.
15. Livraghi T, Goldberg SN, Lazzaroni S, et al. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology. 1999;210:655-661.
16. Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228:235-240.
17. Lin SM, Lin CJ, Lin CC, et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut. 2005;54:1151-1156.
18. Lin SM, Lin CJ, Lin CC, et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma or 4 cm. Gastroenterology. 2004;127:1714-1723.
19. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radio frequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology. 2005;129:122-130.
20. Buscarini L, Buscarini E, Di Stasi M, et al. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol. 2001;11:914-921.
21. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234:961-967.
22. Raut CP, Izzo F, Marra P, et al. Signi?cant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol. 2005;12:616-628.
23. Machi J, Bueno RS, Wong LL. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg. 2005;29:1364-1373.
24. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer. 2005;103: 1201-1209.
25. Cabassa P, Donato F, Simeone F, et al. Radiofrequency ablation of hepato- cellular carcinoma: long-term experience with expandable needle electrodes. Am J Roentgenol. 2006;186:S316-S321.
26. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a ?rst-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol. 2007;17:684-692.
27. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164-1171.
28. Llovet JM, Real MI, Montana X, et al.; Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734-1739.
29. Llovet JM, Bruix J. Systemic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429-442.
30. Chok KS, Ng KK, Poon RT, et al. Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization. Arch Surg. 2006;141:1231-1236.
31. Sala M, Llovet JM, Vilana R, et al.; Barcelona Clinic Liver Cancer Group. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology. 2004;40:1352-1360.
32. Takahashi S, Kudo M, Chung H, et al. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology. 2007;72:98-103.
33. Guglielmi A, Ruzzenente A, Sandri M, et al. Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. J Gastrointest Surg. 2007;11:143-149.
34. Zhang YJ, Liang HH, Chen MS, et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology. 2007;244:599-607.
35. Cheng BQ, Jia CQ, Liu CT, et al. Chemoembolization combined with radiofre- quency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA. 2008;299:1669-1677.
36. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699.
37. Figueras J, Ibanez L, Ramos E, et al. Selection criteria for liver transplanta- tion in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transpl. 2001;7:877-883.
38. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434-1440.
39. Maddala YK, Stadheim L, Andrews JC, et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemo- embolization. Liver Transpl. 2004;10:449-455.
40. Yao FY, Bass NM, Ascher NL, et al. Liver transplantation for hepatocellular carcinoma: lessons from the ?rst year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transpl. 2004;10:621-630.
41. Mazzaferro V, Battiston C, Perrone S, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg. 2004;240:900-909.
42. Fisher RA, Maluf D, Cotterell AH, et al. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin Transplant. 2004;18: 502-512.
43. Fontana RJ, Hamidullah H, Nghiem H, et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl. 2002;8:1165-1174.
44. Pompili M, Mirante VG, Rondinara G, et al. Percutaneous ablation proce- dures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of ef?cacy at explant analysis and of safety for tumor recurrence. Liver Transpl. 2005;11:1117-1126.
45. Lu DS, Yu NC, Raman SS, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology. 2005;41:1130-1137.
46. Brillet PY, Paradis V, Brancatelli G, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: a prospective study with histopathologic comparison. Am J Roentgenol. 2006;186: S296-S305.
47. Llovet JM, Vilana R, BruC, et al.; Barcelona Clinic Liver Cancer Group. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;33:1124-1129.
48. Livraghi T, Lazzaroni S, Meloni F, et al. Risk of tumor seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 2005;92:856-858.
49. Stigliano R, Marelli L, Yu D, et al. Seeding following percutaneous diagnos- tic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev. 2007;33:437-447.
50. Poon RT, Ng KK, Lam CM, et al. Radiofrequency ablation for subcap- sular hepatocellular carcinoma. Ann Surg Oncol. 2004;11:281-289.
51. Latteri F, Sandonato L, Di Marco V, et al. Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study. Dig Liver Dis. 2008;40:684-689.
52. Huang GT, Lee PH, Tsang YM, et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg. 2005;242:36-42.
53. Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47:82-89.
54. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepa- tocellular carcinoma. Ann Surg. 2006;243:321-328.
55. Lu MD, Kuang M, Liang LJ, et al. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi. 2006;86:801-805.
56. Montorsi M, Santambrogio R, Bianchi P, et al. Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg. 2005;9:62-67.
57. Hong SN, Lee SY, Choi MS, et al. Comparing the outcomes of radiofre- quency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol. 2005; 39:247-252.
58. Lupo L, Panzera P, Giannelli G, et al. Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford). 2007;9:429-434.
59. Guglielmi A, Ruzzenente A, Valdegamberi A, et al. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg. 2008;12:192-198.
60. Taura K, Ikai I, Hatano E, et al. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocel- lular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg. 2006;244:265-273.
61. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol. 2007;14:2319-2329.
62. Lu MD, Yin XY, Xie XY, et al. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Br J Surg. 2005;92:1393-1398.
63. Yang W, Chen MH, Yin SS, et al. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic ef?cacy on early- and late-phase recurrence. Am J Roentgenol. 2006;186:S275-S283.